Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide |
| |
Authors: | Lindgren Maria Rosenthal-Aizman Katri Saar Külliki Eiríksdóttir Emelía Jiang Yang Sassian Meeri Ostlund Pernilla Hällbrink Mattias Langel Ulo |
| |
Affiliation: | Department of Neurochemistry, The Arrhenius Laboratories for Natural Sciences, Stockholm University, SE-106 91 Stockholm, Sweden. mel@neurochem.su.se |
| |
Abstract: | Resistance to chemotherapy limits the effectiveness of anti-cancer drug treatment. Here, we present a new approach to overcome the setback of drug resistance by designing a conjugate of a cell-penetrating peptide and the cytostatic agent methotrexate (MTX). Two different peptides, YTA2 and YTA4, were designed and their intracellular delivery efficiency was characterized by fluorescence microscopy and quantified by fluorometry. MTX was conjugated to the transport peptides and the ability of the peptide-MTX conjugates to inhibit dihydrofolate reductase, the target enzyme of MTX, was found to be 15 and 20 times less potent than MTX. In addition, in vitro studies were performed in a drug resistant cell model using the 100-fold MTX resistant breast cancer cells MDA-MB-231. At a concentration of 1 microM, the peptide-MTX conjugates were shown to overcome MTX resistance and kill the cells more efficiently than MTX alone. Estimated EC50's were determined for MTX, MTX-YTA2 and YTA2 to be 18.5, 3.8 and 20 microM, respectively. In summary, cell-penetrating peptide conjugation of MTX is a new way of increasing delivery, and thereby, the potency of already well-characterized therapeutic molecules into drug resistant tumour cells. |
| |
Keywords: | Ac, acetylated APA, 4-amino-4-deoxy-N10-methyl pteroic acid BOP, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate CPP, cell-penetrating peptide DHFR, dehydrate folate reductase LDH, lactate dehydrogenase MALDI, matrix assisted laser desorption ionization MS, mass spectrometry MTX, methotrexate RP-HPLC, reversed phase high performance liquid chromatography TBTU, 1H-benzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate TFA, trifluoro acetic acid |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|